Feasibility and impact of a mental health chatbot on postpartum mental health: a randomized controlled trial
- PMID: 37560011
- PMCID: PMC10407813
- DOI: 10.1016/j.xagr.2023.100165
Feasibility and impact of a mental health chatbot on postpartum mental health: a randomized controlled trial
Abstract
Background: Perinatal mood disorders are common yet underdiagnosed and un- or undertreated. Barriers exist to accessing perinatal mental health services, including limited availability, time, and cost. Automated conversational agents (chatbots) can deliver evidence-based cognitive behavioral therapy content through text message-based conversations and reduce depression and anxiety symptoms in select populations. Such digital mental health technologies are poised to overcome barriers to mental health care access but need to be evaluated for efficacy, as well as for preliminary feasibility and acceptability among perinatal populations.
Objective: To evaluate the acceptability and preliminary efficacy of a mental health chatbot for mood management in a general postpartum population.
Study design: An unblinded randomized controlled trial was conducted at a tertiary academic center. English-speaking postpartum women aged 18 years or above with a live birth and access to a smartphone were eligible for enrollment prior to discharge from delivery hospitalization. Baseline surveys were administered to all participants prior to randomization to a mental health chatbot intervention or to usual care only. The intervention group downloaded the mental health chatbot smartphone application with perinatal-specific content, in addition to continuing usual care. Usual care consisted of routine postpartum follow up and mental health care as dictated by the patient's obstetric provider. Surveys were administered during delivery hospitalization (baseline) and at 2-, 4-, and 6-weeks postpartum to assess depression and anxiety symptoms. The primary outcome was a change in depression symptoms at 6-weeks as measured using two depression screening tools: Patient Health Questionnaire-9 and Edinburgh Postnatal Depression Scale. Secondary outcomes included anxiety symptoms measured using Generalized Anxiety Disorder-7, and satisfaction and acceptability using validated scales. Based on a prior study, we estimated a sample size of 130 would have sufficient (80%) power to detect a moderate effect size (d=.4) in between group difference on the Patient Health Questionnaire-9.
Results: A total of 192 women were randomized equally 1:1 to the chatbot or usual care; of these, 152 women completed the 6-week survey (n=68 chatbot, n=84 usual care) and were included in the final analysis. Mean baseline mental health assessment scores were below positive screening thresholds. At 6-weeks, there was a greater decrease in Patient Health Questionnaire-9 scores among the chatbot group compared to the usual care group (mean decrease=1.32, standard deviation=3.4 vs mean decrease=0.13, standard deviation=3.01, respectively). 6-week mean Edinburgh Postnatal Depression Scale and Generalized Anxiety Disorder-7 scores did not differ between groups and were similar to baseline. 91% (n=62) of the chatbot users were satisfied or highly satisfied with the chatbot, and 74% (n=50) of the intervention group reported use of the chatbot at least once in 2 weeks prior to the 6-week survey. 80% of study participants reported being comfortable with the use of a mobile smartphone application for mood management.
Conclusion: Use of a chatbot was acceptable to women in the early postpartum period. The sample did not screen positive for depression at baseline and thus the potential of the chatbot to reduce depressive symptoms in this population was limited. This study was conducted in a general obstetric population. Future studies of longer duration in high-risk postpartum populations who screen positive for depression are needed to further understand the utility and efficacy of such digital therapeutics for that population.
Keywords: artificial intelligence; chatbot; digital therapeutics; mental health; perinatal mood; postpartum depression; smartphone app; telehealth.
© 2023 Published by Elsevier Inc.
Figures
Similar articles
-
Effectiveness of a Web-based and Mobile Therapy Chatbot on Anxiety and Depressive Symptoms in Subclinical Young Adults: Randomized Controlled Trial.JMIR Form Res. 2024 Mar 20;8:e47960. doi: 10.2196/47960. JMIR Form Res. 2024. PMID: 38506892 Free PMC article.
-
Chatbot-Delivered Cognitive Behavioral Therapy in Adolescents With Depression and Anxiety During the COVID-19 Pandemic: Feasibility and Acceptability Study.JMIR Form Res. 2022 Nov 22;6(11):e40242. doi: 10.2196/40242. JMIR Form Res. 2022. PMID: 36413390 Free PMC article.
-
Mental Health Chatbot for Young Adults With Depressive Symptoms During the COVID-19 Pandemic: Single-Blind, Three-Arm Randomized Controlled Trial.J Med Internet Res. 2022 Nov 21;24(11):e40719. doi: 10.2196/40719. J Med Internet Res. 2022. PMID: 36355633 Free PMC article. Clinical Trial.
-
Testing the Effectiveness of Adding Group Therapy to Home Visiting Services on Reducing Postpartum Depression in Women with Low Incomes [Internet].Washington (DC): Patient-Centered Outcomes Research Institute (PCORI); 2021 Mar. Washington (DC): Patient-Centered Outcomes Research Institute (PCORI); 2021 Mar. PMID: 38237005 Free Books & Documents. Review.
-
Screening for depression among the general adult population and in women during pregnancy or the first-year postpartum: two systematic reviews to inform a guideline of the Canadian Task Force on Preventive Health Care.Syst Rev. 2022 Aug 22;11(1):176. doi: 10.1186/s13643-022-02022-2. Syst Rev. 2022. PMID: 35996176 Free PMC article. Review.
Cited by
-
Artificial Intelligence and Healthcare: A Journey through History, Present Innovations, and Future Possibilities.Life (Basel). 2024 Apr 26;14(5):557. doi: 10.3390/life14050557. Life (Basel). 2024. PMID: 38792579 Free PMC article. Review.
-
Artificial intelligence in mental health care: a systematic review of diagnosis, monitoring, and intervention applications.Psychol Med. 2025 Feb 6;55:e18. doi: 10.1017/S0033291724003295. Psychol Med. 2025. PMID: 39911020 Free PMC article.
-
Self-Administered Interventions Based on Natural Language Processing Models for Reducing Depressive and Anxiety Symptoms: Systematic Review and Meta-Analysis.JMIR Ment Health. 2024 Aug 21;11:e59560. doi: 10.2196/59560. JMIR Ment Health. 2024. PMID: 39167795 Free PMC article.
-
Debate and Dilemmas Regarding Generative AI in Mental Health Care: Scoping Review.Interact J Med Res. 2024 Aug 12;13:e53672. doi: 10.2196/53672. Interact J Med Res. 2024. PMID: 39133916 Free PMC article.
-
Effectiveness of digital health interventions for perinatal depression: a systematic review and meta-analysis.Oxf Open Digit Health. 2024 Aug 3;2:oqae026. doi: 10.1093/oodh/oqae026. eCollection 2024. Oxf Open Digit Health. 2024. PMID: 40237016 Free PMC article. Review.
References
-
- Davey HL, Tough SC, Adair CE, Benzies KM. Risk factors for sub-clinical and major postpartum depression among a community cohort of Canadian women. Matern Child Health J. 2011;15:866–875. - PubMed
-
- ACOG Committee Opinion No. 757: screening for perinatal depression. Obstet Gynecol. 2018;132:e208–e212. - PubMed
-
- Gelenberg AJ, Freeman MP, Markowitz JC, et al. APA practice guidelines for the treatment of patients with major depressive disorder. Published online, vol. 152; 2010. https://psychiatryonline.org/pb/assets/raw/sitewide/practice_guidelines/...
-
- Cuijpers P, Brännmark JG, van Straten A. Psychological treatment of postpartum depression: a meta-analysis. J Clin Psychol. 2008;64:103–118. - PubMed
-
- Claridge AM. Efficacy of systemically oriented psychotherapies in the treatment of perinatal depression: a meta-analysis. Arch Womens Ment Health. 2014;17:3–15. - PubMed
LinkOut - more resources
Full Text Sources